Homocysteine: a strong signal of B vitamins, a weak lever for the heart

Homocysteine is an amino acid made when the body breaks down methionine, which comes from protein. Clearing it depends on folate, vitamin B12 and vitamin B6, and on the kidneys. That makes blood homocysteine a combined readout of B vitamin status, kidney function and a few common gene variants. It is reported in micromol/L (µmol/L).

The ranges

No major cardiology guideline uses homocysteine to set treatment. The categories above are lab and textbook convention. Online targets of "under 7" or "under 8" µmol/L are opinion; the trials below are the reason guidelines do not chase a number.

What raises and lowers it

• Raises: low B12 (including from long-term metformin or acid-suppressing drugs, or a vegan diet without B12), low folate, low B6, reduced kidney function, older age, male sex, smoking, heavy alcohol use, an underactive thyroid, some drugs such as methotrexate, and variants in the MTHFR gene.
• Lowers: folic acid, B12 and B6 supplements, and correcting deficiency.

Because B12 deficiency raises it, homocysteine is sometimes used with methylmalonic acid to confirm a borderline B12 result. The ADA's 2026 Standards recommend periodic B12 testing in people on long-term metformin.

What it predicts, and what lowering it did

The Homocysteine Studies Collaboration (JAMA, 2002) pooled individual data from 30 studies with 5,073 heart disease events and 1,113 strokes. In the prospective studies, after adjustment for other risk factors, a 25% lower homocysteine, about 3 µmol/L, was associated with 11% lower risk of ischaemic heart disease (odds ratio 0.89) and 19% lower risk of stroke (odds ratio 0.81). The authors called it "at most a modest independent predictor" in healthy populations.

Then came the trials. In HOPE-2 (NEJM, 2006), 5,522 people aged 55 or over with vascular disease or diabetes took folic acid, B6 and B12 or placebo for an average of five years. Homocysteine fell 2.4 µmol/L on treatment and rose 0.8 on placebo. Major cardiovascular events: 18.8% against 19.8%, a relative risk of 0.95 (95% CI 0.84 to 1.07), not significant. Stroke was less common on vitamins (relative risk 0.75), and hospital admission for unstable angina was more common (1.24). Other trials found much the same. So homocysteine predicts risk, but lowering it with B vitamins does not reliably reduce heart attacks.

On GLP-1 drugs and weight loss

There are no pivotal GLP-1 trial data on homocysteine. The relevant links are indirect. Many people starting a GLP-1 for diabetes are also on metformin, which can lower B12. And eating much less, particularly less animal protein, changes B12 and folate intake. If homocysteine rises during treatment, the B vitamins and kidney function are the first things to check.

How to test

• Fast overnight where possible; a protein-rich meal can raise it a little.
• The sample needs prompt handling. Blood cells keep releasing homocysteine into an unseparated sample, so a tube left at room temperature reads falsely high. Labs usually ask for it to be spun or chilled quickly.
• Stop B vitamin supplements for a few days if your clinician wants to see untreated levels, and say so either way.
• Read it with B12, folate and eGFR.

How much weight to put on a single value? Homocysteine varies less from week to week than inflammatory markers such as hs-CRP, but the 2002 meta-analysis needed to correct for regression dilution, the tendency of a single measurement to understate the true link, which tells you one draw is an imperfect estimate of your usual level. Two results a few weeks apart, under the same conditions, are a better baseline. If a high value falls after B12 or folate is corrected, that is a useful finding in itself: it confirms the deficiency was real.

Tracking it in Peptide AI

In Peptide AI, homocysteine sits in the inflammatory panel. The app reads it from a lab PDF or manual entry, scores the panel from 0 to 100 alongside an overall grade, flags values that warrant prompt physician consultation, and plots each result against your dose timeline. Log the draw date, whether you fasted, and anything unusual in the days before, such as illness, a hard session or a dose step, so the next result is compared like with like. Bloodwork tracking shows the series next to the dose log, weight and side effects, and the panels page lists every marker the app groups. More markers are in the bloodwork guides.